Description

The molecule GW501516 better known as Cardarine is among the most interesting research chemicals.

Known as “Cardio in Pills”, GW-501516 was developed by GlaxoSmithKline in the early 1990s.

It is not a SARM, in fact it does not perform anabolic functions, but a PPAR receptor agonist.

It improves endurance, stamina, helps in fat loss, improves the lipid profile, in particular cardarine is useful for increasing the duration of performance, allowing you to train longer and recover faster.

It has no anabolic properties but determines a significant reduction in fat while safeguarding muscle tissue.

Combined with a low-calorie diet it promotes the destruction of adipocytes for energy purposes.

In addition, by leading to a reduction in bad cholesterol with an improvement in HDL (good cholesterol), GW501516 is excellent in combination with other compounds that cause dyslipidemia.

Cardarine is very well suited as a complementary compound to other molecules.

To date, dispelled the myth of the alleged carcinogenic effect of Cardarine, no side effects have been reported.

Disclaimer: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
ALKEMYA BV accepts no liability in case of misuse of this product.